B. Viollet, B. Guigas, J. Leclerc, S. Hebrard, L. Lantier et al., AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state AMPactivated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside, Acta Physiol (Oxf) J Clin Invest Biochem J, vol.1961204044, pp.81-982355, 2007.

S. Hawley, F. Ross, C. Chevtzoff, K. Green, A. Evans et al., Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab, vol.115, pp.554-565, 2010.

M. Foretz, N. Ancellin, F. Andreelli, Y. Saintillan, P. Grondin et al., Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver, Diabetes, vol.54, issue.5, pp.1331-1339, 2005.
DOI : 10.2337/diabetes.54.5.1331

C. Canto, J. Auwerx, J. Baur, K. Pearson, N. Price et al., AMP-activated protein kinase and its downstream transcriptional pathways Resveratrol improves health and survival of mice on a high-calorie diet, Cell Mol Life Sci Nature Gwinn DM, vol.67444, pp.3407-3423337, 2006.

A. Meijer and P. Codogno, AMP-Activated Protein Kinase and Autophagy, Autophagy, vol.3, issue.3, pp.238-240, 2007.
DOI : 10.4161/auto.3710

URL : https://hal.archives-ouvertes.fr/inserm-00175293

B. Cool, B. Zinker, W. Chiou, L. Kifle, N. Cao et al., Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metabolism, vol.3, issue.6, pp.403-416, 2006.
DOI : 10.1016/j.cmet.2006.05.005